CME/CE Podcast

Sanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Health Network
Professor of Medicine
Temple University
Philadelphia, Pennsylvania

Listen to Dr. Agarwala provide answers on frequently asked questions about biosimilars:

1. Where is the US on the “learning curve” with regard to biosimilars?
   Listen
   
   
2. How comfortable are US health care providers with the safety and efficacy data available for biosimilars?
   Listen
   
   
3. Are clinicians drawing on the European experience with biosimilars to inform understanding?
   Listen
   
   
4. What are the challenges ahead for the integration of biosimilars into clinical practice?
   Listen
   
   
5. What is the current status of states legislation related to interchangeability?
   Listen
   
   
6. What are the considerations for P&T committees regarding biosimilars?
   Listen
   
   
7. Can you comment on the importance of patient education related to biosimilars?
   Listen
   
   
8. What new developments related to biosimilars are anticipated in 2016?
   Listen